{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:21:28Z","timestamp":1793370088777,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15840-7","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:45:25Z","timestamp":1773027925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic value of peripheral blood fibrinogen-to-albumin ratio in pancreatic cancer patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jingjing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"1","key":"15840_CR1","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"15840_CR2","first-page":"115","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"15840_CR3","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"15840_CR4","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"issue":"5","key":"15840_CR5","first-page":"375","volume":"70","author":"AJ Grossberg","year":"2020","unstructured":"Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020;70(5):375\u2013403.","journal-title":"CA Cancer J Clin"},{"issue":"10039","key":"15840_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73\u201385.","journal-title":"Lancet"},{"issue":"3","key":"15840_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11605-014-2725-8","volume":"19","author":"B Kulemann","year":"2015","unstructured":"Kulemann B, Hoeppner J, Wittel U, Glatz T, Keck T, Wellner UF, et al. Perioperative and long-term outcome after standard pancreaticoduodenectomy, additional portal vein and multivisceral resection for pancreatic head cancer. J Gastrointest Surg. 2015;19(3):438\u201344.","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"15840_CR8","doi-asserted-by":"publisher","first-page":"e1000267","DOI":"10.1371\/journal.pmed.1000267","volume":"7","author":"S Gillen","year":"2010","unstructured":"Gillen S, Schuster T, Meyer Zum B\u00fcschenfelde C, Friess H, Kleeff J. Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7(4):e1000267.","journal-title":"PLoS Med"},{"issue":"6","key":"15840_CR9","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","volume":"269","author":"VP Groot","year":"2019","unstructured":"Groot VP, Gemenetzis G, Blair AB, Rivero-Soto RJ, Yu J, Javed AA, et al. Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma. Ann Surg. 2019;269(6):1154\u201362.","journal-title":"Ann Surg"},{"issue":"7","key":"15840_CR10","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","volume":"164","author":"X Jiang","year":"2023","unstructured":"Jiang X, Ma Y, Wang T, Zhou H, Wang K, Shi W, et al. Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress. Gastroenterology. 2023;164(7):1232\u201347.","journal-title":"Gastroenterology"},{"key":"15840_CR11","doi-asserted-by":"crossref","unstructured":"Min L, Ziyu D, Xiaofei Z, Shunhe X, Bolin W. Analysis of levels and Clinical value of CA19-9, NLR and SIRI in patients with Pancreatic Cancer with different Clinical Features. Cell Mol Biol (Noisy-le-grand). 2022;67(5):302\u20138.","DOI":"10.14715\/cmb\/2021.67.4.41"},{"issue":"1","key":"15840_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.21037\/gs-21-848","volume":"11","author":"H Huang","year":"2022","unstructured":"Huang H, Sun J, Jiang Z, Zhang X, Li Z, Zhu H, et al. Risk factors and prognostic index model for pancreatic cancer. Gland Surg. 2022;11(1):186\u201395.","journal-title":"Gland Surg"},{"key":"15840_CR13","doi-asserted-by":"crossref","unstructured":"Neumann CCM, Schneider F, Hilfenhaus G, Vecchione L, Felsenstein M, Ihlow J et al. Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients-A Single-Center Analysis of 1294 Patients within the Last Decade. Cancers (Basel). 2023;15(8).","DOI":"10.3390\/cancers15082367"},{"issue":"1","key":"15840_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12885-020-6602-4","volume":"20","author":"S Takano","year":"2020","unstructured":"Takano S, Yoshitomi H, Kagawa S, Furukawa K, Takayashiki T, Kuboki S, et al. Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy. BMC Cancer. 2020;20(1):111.","journal-title":"BMC Cancer"},{"issue":"5","key":"15840_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-019-0510-x","volume":"121","author":"E Campello","year":"2019","unstructured":"Campello E, Ilich A, Simioni P, Key NS. The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Br J Cancer. 2019;121(5):359\u201371.","journal-title":"Br J Cancer"},{"key":"15840_CR16","doi-asserted-by":"publisher","first-page":"1149942","DOI":"10.3389\/fonc.2023.1149942","volume":"13","author":"C Li","year":"2023","unstructured":"Li C, Fan Z, Guo W, Liang F, Mao X, Wu J, et al. Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer. Front Oncol. 2023;13:1149942.","journal-title":"Front Oncol"},{"issue":"12","key":"15840_CR17","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1245\/s10434-021-10027-9","volume":"28","author":"GT Lin","year":"2021","unstructured":"Lin GT, Ma YB, Chen QY, Zhong Q, Zheng CH, Li P, et al. Fibrinogen-Albumin Ratio as a New Promising Preoperative Biochemical Marker for Predicting Oncological Outcomes in Gastric Cancer: A Multi-institutional Study. Ann Surg Oncol. 2021;28(12):7063\u201373.","journal-title":"Ann Surg Oncol"},{"key":"15840_CR18","doi-asserted-by":"publisher","first-page":"175883592110228","DOI":"10.1177\/17588359211022886","volume":"13","author":"HQ Ying","year":"2021","unstructured":"Ying HQ, Sun F, Liao YC, Cai D, Yang Y, Cheng XX. The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer. Ther Adv Med Oncol. 2021;13:17588359211022886.","journal-title":"Ther Adv Med Oncol"},{"key":"15840_CR19","doi-asserted-by":"crossref","unstructured":"Claps F, Rai S, Mir MC, van Rhijn BWG, Mazzon G, Davis LE et al. Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy. Urol Oncol. 2021;39(12):835.e9-.e17.","DOI":"10.1016\/j.urolonc.2021.04.026"},{"key":"15840_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"15840_CR21","doi-asserted-by":"publisher","first-page":"110200","DOI":"10.1016\/j.intimp.2023.110200","volume":"119","author":"L Zhang","year":"2023","unstructured":"Zhang L, Kuang T, Chai D, Deng W, Wang P, Wang W. The Use of Antibiotics During Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Advanced Esophagogastric Cancer. Int Immunopharmacol. 2023;119:110200.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"15840_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13643-025-02752-z","volume":"14","author":"JF Tierney","year":"2025","unstructured":"Tierney JF, Burdett S, Fisher DJ. Practical methods for incorporating summary time-to-event data into meta-analysis: updated guidance. Syst Rev. 2025;14(1):84.","journal-title":"Syst Rev"},{"issue":"1","key":"15840_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12935-025-04051-y","volume":"25","author":"Z Jamalpoor","year":"2025","unstructured":"Jamalpoor Z, Aghayan AH, Mirzaei E, Mohammadi D, Atashi A. Assessing the prognostic value of long non-coding RNAs in glioblastoma patients: findings from a systematic review and meta-analysis. Cancer Cell Int. 2025;25(1):416.","journal-title":"Cancer Cell Int"},{"key":"15840_CR24","doi-asserted-by":"publisher","first-page":"104884","DOI":"10.1016\/j.critrevonc.2025.104884","volume":"215","author":"AH Aghayan","year":"2025","unstructured":"Aghayan AH, Bayani A, Abbaspour M, Gharehchahi F, Soleimani Samarkhazan H. Extracellular vesicle-based biomarkers in diffuse large B-cell lymphoma: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2025;215:104884.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"15840_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"15840_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1186\/s12885-024-12579-x","volume":"24","author":"W Ma","year":"2024","unstructured":"Ma W, Shi Q, Zhang L, Qiu Z, Kuang T, Zhao K, et al. Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies. BMC Cancer. 2024;24(1):830.","journal-title":"BMC Cancer"},{"issue":"1","key":"15840_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12935-023-03028-z","volume":"23","author":"Y Mirazimi","year":"2023","unstructured":"Mirazimi Y, Aghayan AH, Keshtkar A, Mottaghizadeh Jazi M, Davoudian A, Rafiee M. CircRNAs in diagnosis, prognosis, and clinicopathological features of multiple myeloma; a systematic review and meta-analysis. Cancer Cell Int. 2023;23(1):178.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"15840_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12937-024-01037-w","volume":"23","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang K, Liu R, Kuang T, Chen C, Yao F, et al. Body composition as a prognostic factor in cholangiocarcinoma: a meta-analysis. Nutr J. 2024;23(1):145.","journal-title":"Nutr J"},{"issue":"11","key":"15840_CR29","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.62347\/ZOHP7650","volume":"16","author":"H Cheng","year":"2024","unstructured":"Cheng H, Lu D, Yin C, Fang Y. Prognostic value of peripheral blood fibrinogen-to-albumin ratio and neutrophil-to-lymphocyte ratio in patients with locally advanced or metastatic pancreatic cancer. Am J Transl Res. 2024;16(11):7165\u201375.","journal-title":"Am J Transl Res"},{"issue":"2","key":"15840_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.hbpd.2022.09.009","volume":"22","author":"S Xu","year":"2023","unstructured":"Xu S, Zhang XP, Zhao GD, Zou WB, Zhao ZM, Liu Q, et al. Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. Hepatobiliary Pancreat Dis Int. 2023;22(2):160\u20138.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"15840_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4143\/crt.2020.330","volume":"53","author":"L Fang","year":"2021","unstructured":"Fang L, Yan FH, Liu C, Chen J, Wang D, Zhang CH, et al. Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer. Cancer Res Treat. 2021;53(1):131\u20139.","journal-title":"Cancer Res Treat"},{"key":"15840_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/CMAR.S275173","volume":"13","author":"S Deng","year":"2021","unstructured":"Deng S, Fan Z, Xia H, Gong Y, Qian Y, Huang Q, et al. Fibrinogen\/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms. Cancer Manag Res. 2021;13:107\u201315.","journal-title":"Cancer Manag Res"},{"issue":"46","key":"15840_CR33","doi-asserted-by":"publisher","first-page":"7382","DOI":"10.3748\/wjg.v26.i46.7382","volume":"26","author":"LP Zhang","year":"2020","unstructured":"Zhang LP, Ren H, Du YX, Wang CF. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection. World J Gastroenterol. 2020;26(46):7382\u2013404.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"15840_CR34","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.21873\/anticanres.14727","volume":"40","author":"K Tomita","year":"2020","unstructured":"Tomita K, Ochiai S, Gunji T, Hikita K, Kobayashi T, Sano T, et al. Prognostic Significance of Plasma Fibrinogen\/Serum Albumin Ratio in the Postoperative Outcome of Pancreatic Ductal Adenocarcinoma. Anticancer Res. 2020;40(12):7017\u201323.","journal-title":"Anticancer Res"},{"issue":"27","key":"15840_CR35","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.2174\/092986707782360015","volume":"14","author":"RA Adams","year":"2007","unstructured":"Adams RA, Schachtrup C, Davalos D, Tsigelny I, Akassoglou K. Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis. Curr Med Chem. 2007;14(27):2925\u201336.","journal-title":"Curr Med Chem"},{"issue":"7225","key":"15840_CR36","first-page":"36","volume":"457","author":"A Mantovani","year":"2009","unstructured":"Mantovani A, Cancer. Inflaming metastasis Nat. 2009;457(7225):36\u20137.","journal-title":"Inflaming metastasis Nat"},{"issue":"6","key":"15840_CR37","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"issue":"7","key":"15840_CR38","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-09-3465","volume":"70","author":"KA Steinbrecher","year":"2010","unstructured":"Steinbrecher KA, Horowitz NA, Blevins EA, Barney KA, Shaw MA, Harmel-Laws E, et al. Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen. Cancer Res. 2010;70(7):2634\u201343.","journal-title":"Cancer Res"},{"issue":"6","key":"15840_CR39","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/bjc.2014.393","volume":"111","author":"LQ Tang","year":"2014","unstructured":"Tang LQ, Chen QY, Guo SS, Chen WH, Li CF, Zhang L, et al. The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study. Br J Cancer. 2014;111(6):1102\u201311.","journal-title":"Br J Cancer"},{"issue":"11","key":"15840_CR40","first-page":"2720","volume":"133","author":"L Sheng","year":"2013","unstructured":"Sheng L, Luo M, Sun X, Lin N, Mao W, Su D. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. Int J Cancer. 2013;133(11):2720\u20135.","journal-title":"Int J Cancer"},{"issue":"3","key":"15840_CR41","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1097\/MPA.0b013e3181987d86","volume":"38","author":"Q Guo","year":"2009","unstructured":"Guo Q, Zhang B, Dong X, Xie Q, Guo E, Huang H, et al. Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor. Pancreas. 2009;38(3):e75\u20139.","journal-title":"Pancreas"},{"issue":"8","key":"15840_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/MPA.0000000000000889","volume":"46","author":"K Ishigaki","year":"2017","unstructured":"Ishigaki K, Nakai Y, Isayama H, Saito K, Hamada T, Takahara N, et al. Thromboembolisms in Advanced Pancreatic Cancer: A Retrospective Analysis of 475 Patients. Pancreas. 2017;46(8):1069\u201375.","journal-title":"Pancreas"},{"issue":"12","key":"15840_CR43","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1002\/cncr.26600","volume":"118","author":"AS Epstein","year":"2012","unstructured":"Epstein AS, Soff GA, Capanu M, Crosbie C, Shah MA, Kelsen DP, et al. Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer. Cancer. 2012;118(12):3053\u201361.","journal-title":"Cancer"},{"issue":"23","key":"15840_CR44","first-page":"6966","volume":"62","author":"JS Palumbo","year":"2002","unstructured":"Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res. 2002;62(23):6966\u201372.","journal-title":"Cancer Res"},{"issue":"5","key":"15840_CR45","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1349-7006.2009.01115.x","volume":"100","author":"S Zheng","year":"2009","unstructured":"Zheng S, Shen J, Jiao Y, Liu Y, Zhang C, Wei M, et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci. 2009;100(5):859\u201365.","journal-title":"Cancer Sci"},{"issue":"11","key":"15840_CR46","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/cas.12797","volume":"106","author":"C Zhao","year":"2015","unstructured":"Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang L, et al. Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis. Cancer Sci. 2015;106(11):1596\u2013606.","journal-title":"Cancer Sci"},{"issue":"12","key":"15840_CR47","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1073\/pnas.1221602110","volume":"110","author":"MM Martino","year":"2013","unstructured":"Martino MM, Briquez PS, Ranga A, Lutolf MP, Hubbell JA. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U S A. 2013;110(12):4563\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15840_CR48","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/1471-2407-14-566","volume":"14","author":"YJ Shu","year":"2014","unstructured":"Shu YJ, Weng H, Bao RF, Wu XS, Ding Q, Cao Y, et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer. 2014;14:566.","journal-title":"BMC Cancer"},{"issue":"13","key":"15840_CR49","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1158\/0008-5472.CAN-18-3206","volume":"79","author":"Y Yang","year":"2019","unstructured":"Yang Y, Stang A, Schweickert PG, Lanman NA, Paul EN, Monia BP, et al. Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion. Cancer Res. 2019;79(13):3417\u201330.","journal-title":"Cancer Res"},{"key":"15840_CR50","doi-asserted-by":"crossref","unstructured":"Chowdhury NN, Mitchell DK, Kangro K, Eldridge K, Abrahams S, Ferraresso F et al. Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma. Gastroenterology. 2025.","DOI":"10.1053\/j.gastro.2025.09.024"},{"issue":"2","key":"15840_CR51","first-page":"301","volume":"100","author":"CP Hodgkinson","year":"2008","unstructured":"Hodgkinson CP, Patel K, Ye S. Functional Toll-like receptor 4 mutations modulate the response to fibrinogen. Thromb Haemost. 2008;100(2):301\u20137.","journal-title":"Thromb Haemost"},{"key":"15840_CR52","doi-asserted-by":"publisher","first-page":"607209","DOI":"10.3389\/fcell.2020.607209","volume":"8","author":"S Yang","year":"2020","unstructured":"Yang S, Liu Q, Liao Q. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming. Front Cell Dev Biol. 2020;8:607209.","journal-title":"Front Cell Dev Biol"},{"key":"15840_CR53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.critrevonc.2018.05.006","volume":"127","author":"M Sadeghi","year":"2018","unstructured":"Sadeghi M, Keshavarz-Fathi M, Baracos V, Arends J, Mahmoudi M, Rezaei N. Cancer cachexia: Diagnosis, assessment, and treatment. Crit Rev Oncol Hematol. 2018;127:91\u2013104.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1\u20132","key":"15840_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0169-5002(95)00407-R","volume":"12","author":"E Espinosa","year":"1995","unstructured":"Espinosa E, Feliu J, Zamora P, Gonz\u00e1lez Bar\u00f3n M, S\u00e1nchez JJ, Ord\u00f3n ez A, et al. Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer. Lung Cancer. 1995;12(1\u20132):67\u201376.","journal-title":"Lung Cancer"},{"issue":"8","key":"15840_CR55","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.gassur.2004.09.033","volume":"8","author":"YC Lien","year":"2004","unstructured":"Lien YC, Hsieh CC, Wu YC, Hsu HS, Hsu WH, Wang LS, et al. Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg. 2004;8(8):1041\u20138.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"15840_CR56","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ijc.20871","volume":"115","author":"S Loeffler","year":"2005","unstructured":"Loeffler S, Fayard B, Weis J, Weissenberger J. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer. 2005;115(2):202\u201313.","journal-title":"Int J Cancer"},{"key":"15840_CR57","doi-asserted-by":"crossref","unstructured":"Peker P, Ge\u00e7gel A, Y\u0131lmaz S, C\u0131r\u0131k C, Selvi S, Bozkurt Duman B et al. Prognostic Value of CONUT and ALBI in Metastatic Pancreatic Cancer: A Retrospective Cohort Study. Diagnostics (Basel). 2025;15(24).","DOI":"10.3390\/diagnostics15243161"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15840-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:04:34Z","timestamp":1776254674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15840-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15840"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15840-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study was a meta-analysis based exclusively on previously published anonymized aggregate data and did not involve direct patient recruitment or access to identifiable individual-level information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"482"}}